()

The immediate outlook is clouded by a massive 18% earnings contraction and a stock price that has recently slipped below its 50-day average, suggesting weak near-term momentum despite the spin-off event. However, the long-term picture is compelling: the company trades at a forward P/E of roughly 22x with double-digit expected EPS growth, indicating the market prices in significant future expansion. The balance sheet remains healthy with a current ratio above 1.6, supporting the view that this is a solid buy-and-hold candidate rather than a speculative gamble. Crucially, there is no dividend to rely on for income; investors must depend entirely on capital appreciation driven by the post-spin-off operational focus.